FORM 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): 02/29/2008

LeMaitre Vascular, Inc.

(Exact name of registrant as specified in its charter)

Commission File Number: 001-33092

 

Delaware   04-2825458
(State or other jurisdiction of incorporation)   (IRS Employer Identification No.)

63 Second Avenue

Burlington, MA 01803

(Address of principal executive offices, including zip code)

781-221-2266

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Information to be included in the report

 

Item 2.02. Results of Operations and Financial Condition

On March 4, 2008, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its financial and operational results for the fourth quarter and fiscal year ended December 31, 2007. A copy of the press release is furnished as Exhibit 99.1 to this report.

The information in this report, including the Exhibit attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

After discussions with the Company, and citing external time commitments, Duane M. DeSisto informed the Company on February 29, 2008, that he will not stand for re-election to the Company’s Board of Directors at its annual stockholders meeting to be held in June 2008. Mr. DeSisto’s decision was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

 

Item 9.01. Financial Statements and Exhibits

The following exhibit is furnished as part of this report, where indicated:

(d) Exhibits.

 

Exhibit No.

   

Description

99.1    Press release issued by LeMaitre Vascular, Inc. on March 4, 2008, announcing its financial and operational results for the fourth quarter and fiscal year ended December 31, 2007, furnished herewith.

 

Signature(s)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    LeMaitre Vascular, Inc.
Date: March 4, 2008     By:   /s/ Christopher H. Martin
     

Christopher H. Martin

Assistant Secretary

 

Exhibit Index

 

Exhibit No.

   

Description

EX-99.1    Press release issued by LeMaitre Vascular, Inc. on March 4, 2008, announcing its financial and operational results for the fourth quarter and fiscal year ended December 31, 2007, furnished herewith.